Trial Profile
Pharmacodynamics Study to Investigate the Effect of Evogliptin on Bone Metabolism in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Evogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Jul 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.
- 29 Oct 2015 New trial record